Literature DB >> 21333082

Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis.

Jeffrey J Swigris1, Diane L Fairclough, Marianne Morrison, Barry Make, Elizabeth Kozora, Kevin K Brown, Frederick S Wamboldt.   

Abstract

BACKGROUND: Information on the benefits of pulmonary rehabilitation (PR) in patients with idiopathic pulmonary fibrosis (IPF) is growing, but PR's effects on certain important outcomes is lacking.
METHODS: We conducted a pilot study of PR in IPF and analyzed changes in functional capacity, fatigue, anxiety, depression, sleep, and health status from baseline to after completion of a standard, 6-week PR program.
RESULTS: Six-min walk distance improved a mean ± standard error 202 ± 135 feet (P = .01) from baseline. Fatigue Severity Scale score also improved significantly, declining an average 1.5 ± 0.5 points from baseline. There were trends toward improvement in anxiety, depression, and health status.
CONCLUSIONS: PR improves functional capacity and fatigue in patients with IPF. (Clinical Trials.gov registration NCT00692796.)

Entities:  

Mesh:

Year:  2011        PMID: 21333082      PMCID: PMC3753775          DOI: 10.4187/respcare.00939

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  30 in total

1.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

Review 2.  Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.

Authors:  J J Swigris; W G Kuschner; S S Jacobs; S R Wilson; M K Gould
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

Review 3.  Health-related quality of life among patients with idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Michael K Gould; Sandra R Wilson
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

4.  Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?

Authors:  O Nishiyama; H Taniguchi; Y Kondoh; T Kimura; T Ogawa; F Watanabe; K Nishimura
Journal:  Respir Med       Date:  2005-04       Impact factor: 3.415

5.  Aerobic and strength training in patients with chronic obstructive pulmonary disease.

Authors:  S Bernard; F Whittom; P Leblanc; J Jobin; R Belleau; C Bérubé; G Carrier; F Maltais
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

6.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

7.  Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise.

Authors:  M J Mador; T J Kufel; L A Pineda; A Steinwald; A Aggarwal; A M Upadhyay; M A Khan
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

8.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.

Authors:  Alfred Fishman; Fernando Martinez; Keith Naunheim; Steven Piantadosi; Robert Wise; Andrew Ries; Gail Weinmann; Douglas E Wood
Journal:  N Engl J Med       Date:  2003-05-20       Impact factor: 91.245

9.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

10.  Standardized single breath normal values for carbon monoxide diffusing capacity.

Authors:  R O Crapo; A H Morris
Journal:  Am Rev Respir Dis       Date:  1981-02
View more
  22 in total

1.  Effect of pulmonary rehabilitation on functional exercise capacity and hypoxemia in patients with interstitial lung diseases: a retrospective study.

Authors:  Salvatore Fuschillo; Alberto De Felice; Andrea Elia; Michele Martucci; Carlo Gaudiosi; Dino Vitali; Mauro Maniscalco
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 2.  Optimizing quality of life in patients with idiopathic pulmonary fibrosis.

Authors:  Mirjam J G van Manen; J J Miranda Geelhoed; Nelleke C Tak; Marlies S Wijsenbeek
Journal:  Ther Adv Respir Dis       Date:  2017-01-01       Impact factor: 4.031

3.  The Unmet Educational Needs of Patients with Interstitial Lung Disease. Setting the Stage for Tailored Pulmonary Rehabilitation.

Authors:  Julie Morisset; Bruno-Pierre Dubé; Chris Garvey; Jean Bourbeau; Harold R Collard; Jeffrey J Swigris; Joyce S Lee
Journal:  Ann Am Thorac Soc       Date:  2016-07

4.  Pulmonary rehabilitation: An overview.

Authors:  Bharat Bhushan Sharma; Virendra Singh
Journal:  Lung India       Date:  2011-10

5.  Cardiopulmonary exercise testing in lung transplantation: a review.

Authors:  Katherine A Dudley; Souheil El-Chemaly
Journal:  Pulm Med       Date:  2012-05-14

Review 6.  Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis.

Authors:  Amy L Olson; Kevin K Brown; Jeffrey J Swigris
Journal:  Patient Relat Outcome Meas       Date:  2016-05-17

Review 7.  Exercise training in idiopathic pulmonary fibrosis: is it of benefit?

Authors:  Baruch Vainshelboim
Journal:  Breathe (Sheff)       Date:  2016-06

8.  The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

Authors:  Alex Diamantopoulos; Emily Wright; Katerina Vlahopoulou; Laura Cornic; Nils Schoof; Toby M Maher
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

Review 9.  Managing comorbidities in idiopathic pulmonary fibrosis.

Authors:  Blair G Fulton; Christopher J Ryerson
Journal:  Int J Gen Med       Date:  2015-09-22

Review 10.  Update on therapeutic management of idiopathic pulmonary fibrosis.

Authors:  Argyris Tzouvelekis; Francesco Bonella; Paolo Spagnolo
Journal:  Ther Clin Risk Manag       Date:  2015-03-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.